Hypermobility & Connective Tissue Disorders

  1. Castori M, Morlino S, Celletti C, Ghibellini G, Bruschini M, Grammatico P, Blundo C, Camerota F. 2013. Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type. Am J Med Genet Part A 161A: 2989–3004.

  2. MedlinePlus. “Ehlers-Danlos Syndrome.” MedlinePlus, U.S. National Library of Medicine, https://medlineplus.gov/genetics/condition/ehlers-danlos-syndrome/. Accessed 15 July 2026.

  3. Colman, M., Syx, D., De Wandele, I., Dhooge, T., Symoens, S., & Malfait, F. (2021). Clinical and molecular characteristics of 168 probands and 65 relatives with a clinical presentation of classical Ehlers–Danlos syndrome. Human Mutation, 42, 1294–1306. https://doi.org/10.1002/humu.24258

  4. Collins Hutchinson ML, Liang E, Fuster E, Blitshteyn S. Autonomic symptom burden, comorbidities and quality of life in women with Hypermobility Spectrum Disorders and hypermobile Ehlers-Danlos syndrome. Auton Neurosci. 2025 Dec;262:103356. doi: 10.1016/j.autneu.2025.103356. Epub 2025 Oct 14. PMID: 41118678.

  5. Ruiz Maya, T., Fettig, V., Mehta, L., Gelb, B. D., & Kontorovich, A. R. (2021). Dysautonomia in hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy. American Journal of Medical Genetics Part A, 185A: 3754–3761. https://doi.org/10.1002/ajmg.a.62446

  6. Kulin, D., Holtmann, G., Fairlie, T., Staller, K., Nurko, S., Keefer, L., Drossman, D. A., Jones, M. P., Aziz, Q., & Shah, A. (2026). Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. Alimentary pharmacology & therapeutics, 10.1111/apt.70856. Advance online publication. https://doi.org/10.1111/apt.70856

  7. Hakim A. Hypermobile Ehlers-Danlos Syndrome. 2004 Oct 22 [Updated 2024 Feb 22]. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1279/

  8. Thwaites, P. A., Gibson, P. R., & Burgell, R. E. (2022). Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know. Journal of gastroenterology and hepatology, 37(9), 1693–1709. https://doi.org/10.1111/jgh.15927

  9. Dell'Aversana, D., Provitera, V., Trinchillo, A., Masciarelli, F., Tozza, S., Caporaso, G., Vitale, F., Borreca, I., Areniello, A. R., Ciccarelli, G., Esposito, G., Iodice, R., Dubbioso, R., Manganelli, F., Santoro, L., Castori, M., & Nolano, M. (2026). Distinct sensory and autonomic involvement in hypermobile Ehlers-Danlos syndrome compared with idiopathic small fiber neuropathy: a multimodal study. Scientific reports, 10.1038/s41598-026-60461-6. Advance online publication. https://doi.org/10.1038/s41598-026-60461-6

  10. Brooks, R. S., Grady, J., Lowder, T. W., & Blitshteyn, S. (2021). Prevalence of gastrointestinal, cardiovascular, autonomic and allergic manifestations in hospitalized patients with Ehlers-Danlos syndrome: a case-control study. Rheumatology (Oxford, England), 60(9), 4272–4280. https://doi.org/10.1093/rheumatology/keaa926

  11. Yew, K. S., Kamps-Schmitt, K. A., & Borge, R. (2021). Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. American family physician, 103(8), 481–492.

  12. Ritelli, M., Chiarelli, N., Cinquina, V., Vezzoli, M., Venturini, M., & Colombi, M. (2024). Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center. American Journal of Medical Genetics Part A, 194(2), 174–194. https://doi.org/10.1002/ajmg.a.63426